BIOMAT Database Logo BIOMAT Database Logo

Big insulin-like growth factor II-producing hepatocellular carcinoma associated with hypoglycemia. 1995

S Ishida, and M Noda, and N Kuzuya, and F Kubo, and S Yamada, and T Yamanaka, and O Isozaki, and N Hizuka, and Y Kanazawa
Department of Integrated Medicine, Omiya Medical Center, Jichi Medical School.

A 76-year-old female with a hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) was hospitalized because of fasting hypoglycemia. Her sera contained a low concentration of immunoreactive insulin and insulin-like growth factor (IGF)-I, while the IGF-II level was normal. However, most of the IGF-II consisted of the high molecular weight form (big IGF-II). The tumor tissue contained fetal type of IGF-II mRNA (6.0 kb). Furthermore, we found that one of the four patients examined with HCV-related HCC had big IGF-II in serum. This indicates that non-islet cell tumor hypoglycemia (NICTH) in HCV-related HCC might be accompanied by production of big IGF-II by the tumor.

UI MeSH Term Description Entries
D007003 Hypoglycemia A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH. Fasting Hypoglycemia,Postabsorptive Hypoglycemia,Postprandial Hypoglycemia,Reactive Hypoglycemia,Hypoglycemia, Fasting,Hypoglycemia, Postabsorptive,Hypoglycemia, Postprandial,Hypoglycemia, Reactive
D007335 Insulin-Like Growth Factor II A well-characterized neutral peptide believed to be secreted by the LIVER and to circulate in the BLOOD. It has growth-regulating, insulin-like and mitogenic activities. The growth factor has a major, but not absolute, dependence on SOMATOTROPIN. It is believed to be a major fetal growth factor in contrast to INSULIN-LIKE GROWTH FACTOR I, which is a major growth factor in adults. IGF-II,Multiplication-Stimulating Activity,Somatomedin MSA,IGF-2,Insulin Like Growth Factor II,Insulin-Like Somatomedin Peptide II,Multiplication-Stimulating Factor,Somatomedin A,Factor, Multiplication-Stimulating,Insulin Like Somatomedin Peptide II,Multiplication Stimulating Activity,Multiplication Stimulating Factor
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D005260 Female Females
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal

Related Publications

S Ishida, and M Noda, and N Kuzuya, and F Kubo, and S Yamada, and T Yamanaka, and O Isozaki, and N Hizuka, and Y Kanazawa
Insulin-like growth factor II-producing intra-abdominal hemangiopericytoma associated with hypoglycemia.
December 2001, Journal of gastroenterology,
S Ishida, and M Noda, and N Kuzuya, and F Kubo, and S Yamada, and T Yamanaka, and O Isozaki, and N Hizuka, and Y Kanazawa
Acinar cell carcinoma of the pancreas associated with hypoglycemia: involvement of "big" insulin-like growth factor-II.
October 1998, Journal of gastroenterology,
S Ishida, and M Noda, and N Kuzuya, and F Kubo, and S Yamada, and T Yamanaka, and O Isozaki, and N Hizuka, and Y Kanazawa
Non-islet cell tumor hypoglycemia caused by a big insulin-like growth factor II- producing hepatocellular carcinoma:an autopsy case report.
January 2016, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
S Ishida, and M Noda, and N Kuzuya, and F Kubo, and S Yamada, and T Yamanaka, and O Isozaki, and N Hizuka, and Y Kanazawa
Insulin-like growth factor II-producing metastatic colon cancer with recurrent hypoglycemia.
February 2015, Clinical journal of gastroenterology,
S Ishida, and M Noda, and N Kuzuya, and F Kubo, and S Yamada, and T Yamanaka, and O Isozaki, and N Hizuka, and Y Kanazawa
Hypoglycemia associated with big insulin-like growth factor II produced during development of malignant fibrous histiocytoma.
December 2003, Endocrine journal,
S Ishida, and M Noda, and N Kuzuya, and F Kubo, and S Yamada, and T Yamanaka, and O Isozaki, and N Hizuka, and Y Kanazawa
Hypoglycemia associated with the production of insulin-like growth factor II in adrenocortical carcinoma.
August 2001, Internal medicine (Tokyo, Japan),
S Ishida, and M Noda, and N Kuzuya, and F Kubo, and S Yamada, and T Yamanaka, and O Isozaki, and N Hizuka, and Y Kanazawa
Insulin-like growth factor II in hepatocellular carcinoma.
August 2007, Biomarkers in medicine,
S Ishida, and M Noda, and N Kuzuya, and F Kubo, and S Yamada, and T Yamanaka, and O Isozaki, and N Hizuka, and Y Kanazawa
Production of insulin-like growth factor-II in hepatocellular carcinoma with recurrent hypoglycemia: a case report.
January 2017, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
S Ishida, and M Noda, and N Kuzuya, and F Kubo, and S Yamada, and T Yamanaka, and O Isozaki, and N Hizuka, and Y Kanazawa
Hypoglycemia attributable to insulin-like growth factor-II prohormone-producing metastatic leiomyosarcoma.
January 1999, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
S Ishida, and M Noda, and N Kuzuya, and F Kubo, and S Yamada, and T Yamanaka, and O Isozaki, and N Hizuka, and Y Kanazawa
Paraneoplastic hypoglycemia due to an insulin-like growth factor type-II secreting hepatocellular carcinoma in a dog.
January 2007, Journal of veterinary internal medicine,
Copied contents to your clipboard!